发明名称 |
THERAPEUTIC AGENT FOR AUTOIMMUNE DISEASES COMPRISING PD-1 AGONIST |
摘要 |
Provided is a prophylactic, symptom progress-suppressive, and/or therapeutic agent for an autoimmune disease. The agent lowers the risk of infections and reduces the burden of administration to patients. The prophylactic, symptom progress-suppressive, and/or therapeutic agent includes a PD-1 agonist as an active ingredient and is administered (a) 1 to 10 times within one month from the first administration, (b) in a total PD-1 agonist dose of 20 to 1250 μg/kg, and (c) without requiring administration for at least 3 months after the last administration. |
申请公布号 |
US2014220021(A1) |
申请公布日期 |
2014.08.07 |
申请号 |
US201214237947 |
申请日期 |
2012.08.10 |
申请人 |
Shibayama Shiro;Imai Masamichi |
发明人 |
Shibayama Shiro;Imai Masamichi |
分类号 |
C07K16/28 |
主分类号 |
C07K16/28 |
代理机构 |
|
代理人 |
|
主权项 |
1. A prophylactic, symptom progress-suppressive, and/or therapeutic agent for an autoimmune disease, the agent comprising a PD-1 agonist as an active ingredient, wherein
(a) the agent is administered 1 to 10 times within one month from a first administration; (b) a total dose of the PD-1 agonist is 20 to 1250 μg/kg; and (c) administration of the agent is not necessary for at least 3 months after a last administration. |
地址 |
Ibaraki JP |